Syngene International Limited

₹434.70As of Sun 8 Nov 2026, 12:00 UTC
NSE:SYNGENEHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 4.28%
Div yield 0.29%
ROE 3.88%
Diagnostics & Research
Beta (5Y) 0.04
PE TTM 93.66
TSR TTM (32.94%)
Mkt cap ₹173.1B
ROIC 7.68%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹504
15.89%
(92.45%)
Hold 4|2|12|10|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
4.22
4.69
4.47
4.37
(3.16%)
8.82%
6.78%
7.07%
Revenue₹B
11.80
12.28
12.56
13.09
12.86%
10.81%
9.71%
8.49%
Peers (US$1.760B)
Cap (US$)
PE
3.508B
56.47x
1.613B
74.47x
1.712B
—
Capital
TTM
5Y
10Y
Leveragex
0.987
0.049
0.041
EBIT/Intx
5.101
0.371
0.324
Own earn%
(65.29)
(140.30)
(137.24)
Sh yield%
38.38
21.45
20.64
Owners
Insiders/Inst%
8.53
73.67
Short interest%
5.97
SBC / revenue%
5.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
29